The prospects for these drugs are quite exciting, especially for those with superimposed CVDs, given the fact that these drugs provide an added advantage of cardioprotection via different yet intricately related mechanisms
At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide
However, the composition or function of the fecal microbiome is different from that of the gut microbiota, which should be taken into account
Realistic Weight Loss from GLP-1 Injections With weight loss stories circulating on social media and influencers touting dramatic results, its easy to assume that GLP-1 medications guarantee rapid, massive transformations
Results Efficacy-to-tolerability ratio is lower for women on GLP1R agonists Approximately 70% of people taking a GLP1R agonist for weight loss are female (Fig